SEC Company Response from Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087) (TECX) — Jul 8, 2019
Tectonic Therapeutic, Inc. (TECX) (CIK 0001681087)
Date: July 8, 2019 · CIK: 0001681087 · Accession: 0001193125-19-190535
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232489
Letter
AVROBIO, Inc.
One Kendall Square
Building 300, Suite 201
Cambridge, MA 02139
July 8, 2019
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: AVROBIO, Inc.
Registration Statement on Form S-3 filed July 1, 2019 (File No. 333-232489)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), AVROBIO, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to July 10, 2019, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact James Xu of Goodwin Procter LLP at (617) 570-1483.
Sincerely,
AVROBIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP AVROBIO, Inc. One Kendall Square Building 300, Suite 201 Cambridge, MA 02139 July 8, 2019 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: AVROBIO, Inc. Registration Statement on Form S-3 filed July 1, 2019 (File No. 333-232489) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), AVROBIO, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to July 10, 2019, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. If you have any questions regarding this request, please contact James Xu of Goodwin Procter LLP at (617) 570-1483. Sincerely, AVROBIO, INC. /s/ Geoff MacKay Geoff MacKay President and Chief Executive Officer cc: Erik Ostrowski, AVROBIO, Inc. Arthur R. McGivern, Esq., Goodwin Procter LLP James Xu, Esq., Goodwin Procter LLP